INTRODUCTION
============

Significant effort has been placed into achieving tightly controlled gene expression systems across a spectrum of organisms, guided by the transformative discoveries of gratuitous inducers of the *Escherichia coli* lactose (lac) operon genes. The significant desirable features of a useful induction system include 1) a complete lack of target gene activation in the absence of inducer, 2) rapid induction of a target gene in the presence of inducer, and 3) the availability of a gratuitous inducer (i.e., one that interacts with no unintended regulatory system and thus should be inert with respect to physiology). The gratuitous inducers isopropyl β-[d]{.smallcaps}-1 thiogalactopyranoside (IPTG) and thiomethyl β-[d]{.smallcaps}-galactoside, combined with the extraordinary specificity of lac gene regulation by lac repressor (lacI) and its variants, still most closely approximate the ideal.

Two common approaches in mammalian cells are direct adaptations of bacterial systems: IPTG-inducible lacI-based and tetracycline-inducible tetR-based systems ([@B24]; [@B14]). By expressing a chimeric transcription factor with a eukaryotic activation domain (e.g., VP16) fused to either lacI or tetR, transcription of a target gene downstream of a minimally active promoter with the appropriate operator sites can be maintained at high levels in the absence of inducer. The tetR-VP16 protein, also called tTA (tetracycline transactivator), unbinds DNA in the presence of tetracycline, thereby repressing transcription. This configuration is referred to as tet-off. A mutant of tetR-VP16, named rtTA (reverse tetracycline transactivator), contains a mutated tetR moiety that can bind tet operator sites only in the presence of drug, turning the tet-off system into a tet-on system ([@B15]). An advantage of tetR-based systems over lacI-based systems is that tetR binds tetracycline much more tightly than lacI binds IPTG (k~a~ ∼ 10^9^ M^−1^ for tetR vs. k~a~ ∼ 10^6^ M^−1^ for lacI), allowing experiments to be performed with lower tetracycline concentrations ([@B33]; [@B40]).

Tet-based systems have become widely used in *Saccharomyces cerevisiae*. Tet-off is generally preferred because with tet-on there is considerable transcription in the absence of the inducer, a condition referred to as "leakiness" ([@B4]). A dual expression system, which uses factors that respond reciprocally to tetracycline addition, has significantly reduced the leakiness of tet-on, however ([@B4]). Using gene expression microarrays, it was shown that doxycycline (a commonly used tetracycline analogue) does not have a significant impact on the abundance of *S. cerevisiae* mRNA transcripts ([@B44]). A major limitation of the tet-off system is that it relies on protein dilution and degradation to reduce target protein levels, both of which can be quite slow. In addition, a recent implementation of the tet-on system takes nearly 15 min to reach near-maximal levels of target transcription and by 5 min is only weakly induced ([@B2]).

The most widely used induction system in *S. cerevisiae* uses Gal4p-mediated induction of targets, which are placed downstream of promoters (such as the *GAL1*, *GAL7*, or *GAL10* promoters) containing UAS~GAL~ 17-mer sites, CGG-N~11~-CCG ([@B13]). This motif is recognized by a Gal4p homodimer ([@B28]; [@B19]). Deletion of the galactokinase *GAL1*, which is required for galactose utilization, allows galactose to induce *GAL* genes in a nearly gratuitous manner ([@B20]). Because *GAL* genes are catabolite repressed ([@B1]), rapid activation requires that cells be grown in relatively poor, nonglucose carbon sources before the galactose pulse. This system was used by Chua *et al.* to investigate the transcriptional response of 50+ transcription factors that cause growth inhibition upon overexpression ([@B8]).

Fusion of the Gal4p DNA binding domain (Gal4dbd) to the electronegative portion of herpes simplex virus protein VP16 results in a strong transcriptional activator ([@B37]). Fusion of the hormone binding domain of the human estrogen receptor to Gal4-VP16 results in a strong transcriptional activator that is only active in the presence of β-estradiol ([@B27]), as illustrated in [Figure 1](#F1){ref-type="fig"}. By placing GEV expression under the control of constitutive, low-to-moderate strength promoters, errant expression of target genes is reduced to near-background levels in the absence of β-estradiol ([@B11]; [@B35]; [@B43]). Even though GEV relies on the Gal4dbd to bind DNA, it is not catabolite repressed, providing a significant advantage over the more standard Gal4-based gene induction approach.

![Schematic of the GEV overexpression system. GEV is constitutively expressed from an *ACT1* promoter. Before activation by β-estradiol, GEV is inactive in the cytoplasm, associating with the Hsp90 chaperone complex. β-Estradiol diffuses through the cell membrane and binds to the GEV estrogen receptor domain, resulting in release of GEV from the Hsp90 chaperone complex. GEV then localizes to the nucleus, binds to the UAS~GAL~ consensus sequences, and strongly activates transcription through its VP16 domain.](4447fig1){#F1}

We were motivated to adapt this system further and to characterize it thoroughly because we wanted to carry out a genome-scale screen of yeast transcription factor activities under circumstances that allow us to follow dynamically the consequences of induction with minimal confounding changes. To this end we eliminated any need for plasmids (as in [@B11] and [@B35]) and enabled the use of the system in a prototrophic background with an intact *HAP1* gene. Supplemental Table 1 summarizes in more detail the relative merits of alternative expression systems.

Our adaptation of GEV provides an efficient switch that induces target genes to near maximal levels within minutes following hormone addition to the culture. We show that use of intermediate concentrations of inducer results in a graded response: all the cells in the population produce intermediate amounts of protein. Using a single-cell visualization method, we verify that GEV activation occurs through its rapid nuclear localization in the presence of β-estradiol. We show that GEV induction, even to high levels, results in relatively few gene expression changes, making it a useful tool for overexpression studies in *S. cerevisiae.*

We also developed a modified version of the inducible protein depletion method of [@B42] that allows rapid, specific target protein degradation simply by making the system inducible by β-estradiol using our GEV system. We use GEV to induce the tobacco etch virus (TEV) protease enabling N-end rule degradation ([@B3]) of an appropriately modified target gene driven by its native promoter. We show that the kinetics of degradation are also rapid, resulting in substantial degradation within 15 min after induction of the system. Finally, we show examples illustrating the power of these systems to perturb regulatory networks specifically by introducing (and/or overexpressing) a single regulatory protein by induction with β-estradiol.

RESULTS
=======

The GEV system
--------------

We constructed two isogenic strains of opposite mating type (DBY12020, DBY12021) to use for studies of gene induction/overexpression in *S. cerevisiae*. These strains (see [Table 1](#T1){ref-type="table"}) contain an integrated copy of P*~ACT1~*-GEV, so that GEV is produced constitutively and at relatively high levels. To study dynamically the consequences of induction of a gene, its promoter is replaced by the *GAL1* promoter (P*~GAL1~*) in either DBY12020 or DBY12021. If one wants a fluorescent reporter to monitor induction, one can use DBY12039. To study the consequences of the degradation of a protein, a peptide sequence recognized by TEV (i.e., N-degron sequence) can be appended to the N-terminus of the gene in DBY12132, as described in *Materials and Methods*.

###### 

Strains used in this study.

  Strain     Genotype                                                                                                                                                                                       Source
  ---------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------
  DBY11389   MAT**a**, *ura3Δ0*                                                                                                                                                                             This study
  DBY11408   MATα, *his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, gal10Δ::*KanMX4                                                                                                                                         Open Biosystems
  DBY11415   MAT**a**/MATα, (P*~GAL10~*+*gal1*)Δ::loxP/*GAL1*, *leu2Δ0*::P*~ACT1~*-GEV-GFP-KanMX/*LEU2*, *gal4*Δ::*LEU2/GAL4*, *HTB2-*mCherry-CaUra3/*HTB2*, *his3/HIS3*, *leu2/LEU2*, *hap1^--^/HAP1^+^*   This study
  DBY12020   MAT**a**, (P*~GAL10~*+*gal1*)Δ::loxP, *leu2Δ0*::P*~ACT1~*-GEV-NatMX, *gal4*Δ::*LEU2*, *HAP1^+^*                                                                                                This study
  DBY12021   MATα, (P*~GAL10~*+*gal1*)Δ::loxP, *leu2Δ0*::P*~ACT1~*-GEV-NatMX, *gal4*Δ::*LEU2*, *HAP1^+^*                                                                                                    This study
  DBY12027   MATα, (P*~GAL10~*+*gal1*)Δ::loxP, *leu2Δ0*::P*~ACT1~*-GEV-NatMX, *gal4*Δ::*LEU2*, KanMX4-P*gal1*-*MET4*, *HAP1^+^*                                                                             This study
  DBY12039   MATα, (P*~GAL10~*+*gal1*)Δ::loxP*, leu2Δ0*::P*~ACT1~*-GEV-NatMX, *gal4Δ*::*LEU2*, *ybr032wΔ*::P*~GAL1~*-GFP-NatMX, *HAP1^+^*                                                                   This study
  DBY12040   MATα, (P*~GAL10~*+*gal1*)Δ::loxP, *leu2Δ0*::P*~ACT1~*-GEV-NatMX, *gal4*Δ::*LEU2*, KanMX4-P*~GAL1~*-*CBF1*, *HAP1^+^*                                                                           This study
  DBY12055   MAT**a**, NDeg-*MET4*-13Myc-KanMX, *gal4*Δ::*LEU2*, *gal1*Δ::TEV-HphMX4, *leu2Δ0*::P*~ACT1~*-GEV-NatMX, *HAP1^+^*                                                                              This study
  DBY12086   MATα, (P*~GAL10~*+*gal1*)Δ::loxP, *leu2Δ0*::P*~ACT1~*-GEV-NatMX, *gal4*Δ::*LEU2*, KanMX4-P*~GAL1~*-*TPS2*, *HAP1^+^*                                                                           This study
  DBY12099   MATα, (P*~GAL10~*+*gal1*)Δ::loxP, *leu2Δ0*::P*~ACT1~*-GEV-NatMX, *gal4*Δ::*LEU2*, KanMX4-P*~GAL1~*-*MET4*, *met6Δ*::HphMX4, *HAP1^+^*                                                          This study
  DBY12100   MATα, (P*~GAL10~*+*gal1*)Δ::loxP, *leu2Δ0*::P*~ACT1~*-GEV-NatMX, *gal4*Δ::*LEU2*, *ura3Δ::*HphMX4, *HAP1^+^*                                                                                   This study
  DBY12132   MATα, *gal1*Δ::TEV-*URA3*, *ura3Δ0*, *leu2Δ0*::P*~ACT1~*-GEV-NatMX, *gal4Δ*::*LEU2*, *HAP1^+^*                                                                                                 This study
  DBY12168   MAT**a**/MATα*, gal4Δ*::LEU2/*GAL4,* (P*~GAL10~* + *gal1*)Δ::loxP/*GAL1*-mCherry-NatMX, *leu2Δ0*::P*~ACT1~*-GEV-GFP-KanMX/*LEU2, HAP1^+^/HAP1^+^*                                              This study
  DBY11440   MAT**a**/MATα, *MET4*-13Myc-KanMX/*MET4*, *ura3Δ0/URA3*, *gal1*Δ::TEV-URA3/GAL1, *gal4Δ*::*LEU2*/*GAL4, leu2Δ0*::P*~ACT1~*-GEV-KanMX/*LEU2*, *hap1^--^*/*HAP1^+^*                              This study
  DBY12032   MAT**a**, *leu2Δ0*, *HAP1^+^*                                                                                                                                                                  This study
  DBY12194   MATα, NDeg-*MET31*, *gal1Δ*::TEV-*URA3*, *fcy1*Δ::CreEDB78, *HAP1^+^*                                                                                                                          This study
  DBY12197   MAT**a**, *MET31*-13Myc-KanMX, *can1Δ*::P*~ACT1~*-GEV, lys2, *gal1*Δ::TEV-*URA3*, *HAP1^+^*                                                                                                    This study
  DBY12199   MAT**a**, NDeg-MET31-13Myc-KanMX, *gal1*Δ::TEV-*URA3*, *fcy1Δ*::CreEDB78, *HAP1^+^*                                                                                                            This study
  DBY12200   MATα, *gal1*Δ::TEV-*URA3*, *can1*Δ::P*~ACT1~*-GEV, *gal4Δ*::*LEU2*, *HAP1^+^*                                                                                                                  This study
  DBY12234   DBY12199 x DBY12200                                                                                                                                                                            This study
  DBY12235   DBY12197 x DBY12194                                                                                                                                                                            This study

All strains are s288c. *HAP1^+^* indicates a repaired *HAP1* allele ([@B18]), and *hap1^--^* indicates the partial loss-of-function s288c allele ([@B10]; [@B18]).

Note that a gene whose promoter has been replaced with a *GAL* regulated promoter should be expressed only after addition of β-estradiol to the growth medium; this has been the case with the several dozen constructs we have made. Importantly, although GEV binds DNA via the Gal4p DNA binding domain, it is not subject to inhibition or repression by glucose, making feasible induction and overexpression experiments in standard glucose-containing media simply by the addition of the inducer β-estradiol.

Quantitation of GEV localization
--------------------------------

Generally, hormone receptors localize to the nucleus and activate transcription after binding their cognate ligands ([@B34]). To our knowledge, this model has not been experimentally verified in the case of GEV. Therefore, to study GEV nuclear localization following hormone addition, we constructed a functional (Supplemental Figure 1), chromosomally integrated, C-terminus--tagged GEV-GFP (green fluorescent protein) reporter and measured its localization following pulses of β-estradiol ([Figure 2A](#F2){ref-type="fig"} and Supplemental Movie 1) in single cells. We observed a level of GEV localization that is proportional to the amount of added β-estradiol for a range of concentrations. At higher doses (100 nM to 10 μM), we can see the nuclear localization signal emerging from the background 6--8 min following hormone addition. The initial rate of localization achieved its maximum at concentrations at or above 1 μM β-estradiol.

![Single-cell analyses of a GEV-GFP fusion protein. (A) Measuring nuclear localization of GEV-GFP in the presence of different amounts of β-estradiol in DBY11415. (B) DBY11415 was grown in the presence of 1 μM β-estradiol for 50 min. The input medium was then switched to medium lacking β-estradiol, and the kinetics of delocalization were quantified. (C) Images of single cells from the washout experiment in (B). For each cell, the localization score is defined as the mean of the top 5% of pixel intensities minus the mean pixel intensity over the entire cell.](4447fig2){#F2}

To determine the nuclear residence time of activated GEV after removal of β-estradiol, cells were grown in a flow chamber. For the first 50 min, medium containing 1 μM β-estradiol was flowed over the cells. Then the medium inflow was switched ([Figure 2B](#F2){ref-type="fig"}, black line) to a medium lacking β-estradiol, resulting in an approximately exponential reduction in nuclear fluorescence with time. In this way we determined that the nuclear half-life of GEV is ∼40 min ([Figure 2, B](#F2){ref-type="fig"} and [C](#F2){ref-type="fig"}, and Supplemental Movie 2).

Kinetics of GEV-mediated gene induction
---------------------------------------

To investigate the kinetics of target gene induction by GEV, we inserted P*~GAL1~* in front of various reporter genes ([@B26]). First, we constructed a strain in which P*~GAL1~* is driving transcription of the *CBF1* gene at its native chromosomal locus. The level of *CBF1* transcript, as determined by microarray analysis, reaches ∼70% its maximum by 5 min following addition of 1 μM β-estradiol ([Figure 3A](#F3){ref-type="fig"}). Using fluorescence in situ hybridization (FISH) to monitor transcription in single cells, we observed both the cytoplasmic transcripts and nuclear transcription sites of *CBF1*, as shown in the image from [Figure 3B](#F3){ref-type="fig"}, which was taken 8 min following addition of 1 μM β-estradiol to the culture. We used a P*~GAL1~*-GFP reporter to find the point at which GEV becomes saturated by inducer. The percentage of induced cells is determined (see *Materials and Methods*) over time, and we find that GEV is saturated between 100 nM and 1 μM β-estradiol, as the induction kinetics are similar between these two concentrations ([Figure 3C](#F3){ref-type="fig"}).

![The kinetics of GEV-mediated genetic switch. (A) We followed transcription of P*~GAL1~*-*CBF1* induced by GEV by microarray (strain = DBY12040), with DBY12001 RNA as a reference. Values are zero-normalized. (B) Maximal projection image of *CBF1* transcripts from DBY12040 8 min after β-estradiol addition to the medium (FISH). Active transcription sites of P*~GAL1~*-*CBF1* can be seen in single cells. (C) GEV activation of a P*~GAL1~*-GFP reporter in DBY12039 as measured by flow cytometry.](4447fig3){#F3}

GEV-mediated gene induction shows a graded response
---------------------------------------------------

The generally accepted model for the mechanism of nuclear receptors predicts that subsaturating concentrations of inducer result in a response that is proportional to the concentration of inducer (i.e., exhibit a graded as opposed to switch-like response). Indeed this behavior was reported for GEV by [@B41]). To verify a graded response for our system, we performed experiments in which the population of cells containing P*~GAL1~*-GFP was induced by β-estradiol for 12 h and then quantified by flow cytometry.

At concentrations less than 1 nM β-estradiol, the system is ineffective: the average intensity of the reporter is at nearly the background level ([Figure 4A](#F4){ref-type="fig"}). At 10 nM β-estradiol, GFP intensity is increased but is well below what is achieved at higher inducer concentrations ([Figure 4B](#F4){ref-type="fig"}); the significant point is that all the cells exposed to 10 nM β-estradiol exhibit significant fluorescence, as shown by the shift of the entire distribution to the right ([Figure 4A](#F4){ref-type="fig"}). At 100 nM, the average induction is near maximum and the distribution of cells closely resembles that found for higher, completely saturating concentrations of β-estradiol.

![GEV activity shows a graded response in response to β-estradiol. (A) Flow cytometry data at different doses of β-estradiol. Cells were grown to mid-log phase and incubated with the indicated amount of β-estradiol for 12 h. (B) The mean GFP intensity from histograms in (A) as a function of β-estradiol dose. The Hill coefficient (n~H~) is 0.95 (95% CI, n~H~ = 0.72 to 1.18). The strain used in this experiment is DBY12039.](4447fig4){#F4}

A trade-off between GEV activation and cell growth
--------------------------------------------------

We find that strong GEV activation achieved at high concentrations of β-estradiol results in a slowing of growth ([Figure 5A](#F5){ref-type="fig"}). This is not due to β-estradiol toxicity because the slow growth does not occur in a strain lacking the GEV system. We speculate that this effect could be due to "squelching" ([@B12]), whereby strong transcriptional activators repress off-target genes through titration of the RNA polymerase machinery, and thus reduce the cell\'s capacity for growth. [@B25] have provided evidence in yeast that there is indeed a fitness cost exacted by synthesis of proteins not required for asexual proliferation.

![GEV is a gratuitous inducer at 10 nM β-estradiol without a growth defect. (A) DBY12021 grown in YPD liquid in the presence of β-estradiol. A~600~ was monitored over time, and growth rates were spline-fit (inset). Error bars represent ±1 SD of three replicates. (B) The heat sensitivity of *tps2Δ* is repaired by GEV-mediated induction of *TPS2* with 10 nM β-estradiol. (WT = DBY12001; GEV = DBY12021; GEV + P~GAL1~-*TPS2* = DBY12086).](4447fig5){#F5}

At lower concentrations of β-estradiol (10 nM), the GEV-containing cells no longer show the growth defect ([Figure 5A](#F5){ref-type="fig"}), but are able to induce the P*~GAL1~*-GFP reporter essentially in all the cells nonetheless ([Figure 4A](#F4){ref-type="fig"}). Inducing GEV at 1 μM β-estradiol results in a greater than twofold reduction in growth rate ([Figure 5A](#F5){ref-type="fig"}, inset).

To determine whether physiologically significant expression of target genes can be induced at intermediate (10 nM) levels of induction, where no growth consequence is observed, we designed an experiment in which a lethal defect might be complemented in a GEV-dependent manner. *TPS2* encodes an enzyme that converts trehalose-6-phosphate to trehalose. Deletion of *TPS2* causes a heat-sensitive growth phenotype, likely due to the buildup of trehalose-6-phosphate ([@B9]). By placing *TPS2* downstream of P*~GAL1~*, cells become heat sensitive in the absence of β-estradiol ([Figure 5B](#F5){ref-type="fig"}). Growth is restored to wild-type levels in the presence of 10 nM β-estradiol, and the resulting growth is indistinguishable from wild type ([Figure 5B](#F5){ref-type="fig"}).

This result suggests that maximal induction is not likely to be necessary to achieve physiological levels of protein in all experiments. Intermediate levels of inducer suffice to avoid the growth-inhibiting side effects and complement the deletion. In practice, the system is fast-acting at high (\>100 nM β-estradiol) concentrations, but has increased growth rate inhibition. Even at the highest inducer concentrations, few unintended genes are expressed at early times after induction. Thus the user has a trade-off: if the goal of experiments is just to see which genes are induced first, high concentrations will yield this result; if the goal is longer-term specificity, where speed is not of the essence, low concentrations of inducer can be used. It is not clear that this problem is avoidable: using a less strong promoter than that of *ACT1* to drive GEV produces a system with the mitigated growth effect but at the price of less speedy induction.

GEV induction in chemostats is suitable for dynamically studying the physiological consequences of gene action
--------------------------------------------------------------------------------------------------------------

Because yeast are extremely sensitive to slight changes in the extracellular environment, the ideal growth setting for induction experiments is in the chemostat. Briefly, a chemostat works by flowing fresh medium into a growth vessel, and culture medium is diluted from the vessel at a rate determined by the experimenter. With this experimental setup, we can grow to steady state a culture of cells containing the GEV construct and P*~GAL1~* fused to any gene of interest. In the case in which a gene\'s native promoter is replaced with P*~GAL1~* (in a haploid), the cells are effectively deletion mutants of that gene in the absence of β-estradiol due to the tight repression of P*~GAL1~* in the presence of 2% glucose. By adding β-estradiol to such cultures, we can rapidly and strongly induce the gene of interest and follow the physiological consequences. For the particular case of genes encoding transcription factors, the consequence to be followed is the genome-wide transcriptional response of the cells. The goal is to infer a transcription factor\'s immediate targets and quantify the strength of their response. For those target genes that respond most quickly, the inference of causation is strengthened.

GEV induction in a steady-state culture is nearly gratuitous
------------------------------------------------------------

For this approach to be effective, GEV needs to be nearly gratuitous, meaning that it does not have a large effect on the transcriptional landscape of the cell. Although this definition is slightly ambiguous, we can define a large effect as one that results in strong increases/decreases in many genes such that it becomes difficult to separate changes due to overexpressing the target gene from those due to background. By growing a strain (DBY12021) that contains GEV in a chemostat, we find that GEV can be nearly gratuitous ([Figure 6A](#F6){ref-type="fig"}). In DBY12021, the *GAL1* and *GAL4* genes are deleted, as is the *GAL10* promoter. Two hours following addition of saturating (1 μM) β-estradiol, 105 genes decreased twofold (Supplemental data set 1) and 94 genes increased twofold (Supplemental data set 2; Supplemental Figure 7). This finding accounts for ∼3% of all *S. cerevisiae* genes. Although this can be seen as modest compared with all yeast genes, it is nevertheless more than one sees in many deletion mutants, including transcription factors ([@B22]; [@B21]). By using the gene ontology (GO) term finder to find enriched processes within these groups, we found that repressed genes are most enriched for glucose catabolic processes (corrected p-value = 8.49 × 10^−9^) and activated genes are most enriched for oxidation-reduction processes (corrected p-value = 1.73 × 10^−7^). Note that at 18 min following addition of 1 μM β-estradiol, a total of 57 genes have changed twofold (Supplemental Figure 7).

![(A) Hierarchical clustering of gene expression of DBY12021 grown to steady state in a phosphate-limited chemostat with a doubling time of 4.3 h, and at t = 0 min, pulsed with 1 μM β-estradiol. (B) The transcriptional response of the *GAL* genes from (A). (C) Transcriptional response of *YPL066W* and *YPL067C* in (A). (D) The 10 most strongly repressed genes in (A). Clusters in (B) and (D) were hierarchically clustered.](4447fig6){#F6}

GEV induction results in strong activation of *GAL2* and *GAL7* and moderate induction of *GAL3*, *GAL5*, and *GAL80* ([Figure 6B](#F6){ref-type="fig"}). Surprisingly, despite the removal of the *GAL10* promoter by loxP in DBY12021, we observe slight induction of *GAL10* over the course of the experiment.

We found two genes (*YPL067C* and *YPL066W*) that are divergently transcribed in response to GEV induction ([Figure 6C](#F6){ref-type="fig"}). These genes are reminiscent of *GAL1* and *GAL10*, which are divergently transcribed in response to Gal4p activation. *YPL066W* and *YPL067C* are separated by a 385-nucleotide region. This region contains a single UAS~GAL~ sequence, which is conserved upstream of the *YPL066W* and *YPL067C* orthologues in *Saccharomyces mikatae* and *Saccharomyces paradoxus*. Despite the conservation of the Gal4p binding site, these genes have no known role in galactose metabolism and are of unknown function.

The most strongly repressed gene by 2 h following GEV activation is *HSP30* (17.4-fold). The 10 genes most strongly repressed at 2 h following GEV activation are shown in [Figure 6D](#F6){ref-type="fig"}. We could not find any significant correlation with annotated functions that these genes might hold in common.

Using GEV overexpression to probe kinetics of transcriptional regulatory networks
---------------------------------------------------------------------------------

Large-scale ChIP-chip studies have defined extensive transcription factor--DNA binding maps, yielding a highly informative, although static, view of genetic regulation. Using the GEV system to induce rapid and high-level expression of a single transcription factor, we can look at the dynamics of target gene activation or repression.

As an example and proof of principle, we induced the *MET4* gene, which encodes a well-studied, strong transcriptional activator of sulfur metabolic genes in *S. cerevisiae.* A strain containing P*~GAL1~-MET4* was grown to steady state in a phosphate-limited chemostat containing high levels of extracellular methionine, a condition in which Met4p is supposed to be less active. By hierarchically clustering the transcriptional profile of the sulfur metabolic genes as a time series up to 90 min following *MET4* induction, we were able to observe that the kinetics of *MET4*-target induction can vary from gene to gene ([Figure 7](#F7){ref-type="fig"}).

![Quantifying the kinetics of *MET4*\'s downstream targets. DBY12027 (GEV, P*~GAL1~*-*MET4*) was grown to steady state in a phosphate-limited chemostat with excess methionine (200 mg/l) with a doubling time of 4.3 h. At t = 0 min, cells were pulsed with 1 μM β-estradiol. Left, hierarchical clustering of the sulfur metabolic genes with three clearly identifiable categories based on kinetics. Right, the mean expression of genes in each category is plotted (color) along with individual traces (gray). Error bars represent ±1 SD of the mean.](4447fig7){#F7}

We divide the targets into three categories based on their kinetic profiles: strongly induced (group 1), weakly induced (group 2), and uninduced (group 3) (*G1*, *G2,* and *G3*, respectively, in [Figure 7](#F7){ref-type="fig"}). The *MUP1* and *MUP3* genes, which encode the high- and low-affinity methionine permeases, respectively, and *SAM1* and *SAM2*, which encode enzymes that catalyze the synthesis of *S*-adenosylmethionine (AdoMet), are strongly induced group 1 genes. AdoMet is the primary source of methyl donor groups in the cell.

The *MET31* and *MET32* genes encode homologous zinc-finger proteins (46% identical), which aid in the recruitment of Met4p to many sulfur metabolic gene promoters. *MET32* is weakly induced (group 2), and we do not detect any induction of *MET31* (group 3). Whereas *met31Δ* and *met32Δ* mutant cells are able to produce their own methionine when grown on minimal medium, *met31Δmet32Δ* double-mutants are methionine auxotrophs. Despite the sequence and functional similarity of these proteins, the observation of differential regulation is suggestive of distinct roles for *MET31* and *MET32*, at least under particular conditions, resulting in retention of both copies during evolution.

GEV-mediated induction of TEV results in rapid degradation of *N*-degron--tagged proteins
-----------------------------------------------------------------------------------------

We chose the *MET4* and *MET31* genes to use in a proof-of-principle experiment to test our version of the [@B42] protein depletion method ([Figure 8](#F8){ref-type="fig"}). We constructed Ndeg-modified *MET4* and *MET31* alleles in separate strains containing P*~ACT1~*-*GEV* and P*~GAL1~*-*TEV* (see *Materials and Methods*). Cells were grown in rich medium (YPD) and treated with 1 μM β-estradiol at ∼2 × 10^7^ cells/ml. Western blots were performed on proteins extracted before the addition of β-estradiol, and at several time points after induction ([Figure 9](#F9){ref-type="fig"}). Treatment of cultures with 1 μM β-estradiol had no effect on levels of Met4p-13Myc or Met31p-13Myc lacking NDeg ([Figure 9, A](#F9){ref-type="fig"} and [B](#F9){ref-type="fig"}). However, 1 μM β-estradiol treatment of NDeg-*MET4* or NDeg-*MET31* cells showed rapid reduction of the NDeg-tagged proteins ([Figure 9, A](#F9){ref-type="fig"} and [B](#F9){ref-type="fig"}). By performing a best fit of the data from 10-, 20-, and 40-min time points to a power law, we find that the half-life of NDeg-Met4p-13Myc is 16 min and that of NDeg-Met31p-13Myc is 13.75 min ([Figure 9C](#F9){ref-type="fig"}).

![(A) GEV is expressed under the regulation of the constitutive *ACT1* promoter. Treatment with β-estradiol induces nuclear entry of GEV and subsequent induction of P*~GAL1~*-driven *TEV*. (B) The target gene of interest (*YFG*) is regulated by its native promoter. TEV protease binding to its cleavage site in NDeg-modified YFG, facilitated by p14-SF3b binding, results in cleavage, exposing the destabilizing amino acid phenylalanine at the N-terminus. Proteasome-mediated digestion of YFG is the result of N-end rule degradation pathway.](4447fig8){#F8}

![(A) Western blot of DBY12055 (NDeg-Met4p-13Myc) and DBY11440 (Met4p-13Myc) before (0′) and after (10′, 20′, and 40′) 1 μM β-estradiol addition to the culture. (B) Western blot of DBY12234 (NDeg-Met31p-13Myc) and DBY12235 (Met31p-13Myc) before (0′) and after (10′, 20′, and 40′) 1 μM β-estradiol addition to the culture. (C) Normalized protein levels from experiments in (A) and (B) with DBY12055 and DBY12199. Protein levels were quantified in ImageJ and then fitted to a power law for the 10′, 20′, and 40′ time points.](4447fig9){#F9}

A *met4* null allele has a growth defect and produces small colonies on YPD plates ([@B17]). We therefore started with a diploid cell for construction of NDeg-*MET4*. Sporulation of this diploid followed by dissection of the resulting tetrads showed that the spore colonies had the same wild-type size, confirming that the modified gene was functional.

Met4p is known to be ubiquitinated ([@B36]) and is, as a result, unstable. We observed three clear bands in our Met4p Western blots, consistent with the presence of nonubiquitinated Met4p in addition to heavier ubiquitinated forms ([Figure 9A](#F9){ref-type="fig"}). When *MET4* is tagged with NDeg, both the ubiquitinated and nonmodified Met4p proteins are targeted for degradation by TEV ([Figure 9A](#F9){ref-type="fig"}). This finding demonstrates that even heavily modified forms of a protein can be cleaved by TEV.

Finally, we assayed the phenotypic effect of β-estradiol treatment of NDeg-*MET4--*containing cells. As expected, only cells treated with β-estradiol displayed a methionine auxotrophy (*met ^--^*) phenotype (Supplemental Figure 8), as Met4p is required for methionine synthesis ([@B30]).

DISCUSSION
==========

The data presented show that the GEV system, as we configured it, satisfies the requirements of an effective and nearly gratuitous induction system. It can be used to rapidly induce a target gene in every cell in a culture while conferring minimal induction of off-target genes. GEV provides efficient induction. Transcription rates in *S. cerevisiae* measured in the literature range from 0.7 to 2 kb/min ([@B29]; [@B45]), the upper bound of which has been measured from a P*~GAL1~*-driven gene ([@B29]). If a gene is 2 kb in length and is downstream of P*~GAL1~*, as in the case of P*~GAL1~*-*MET4*, generating a full transcript should take 1 min. By 2.5 min, we observed detectable amounts of P*~GAL1~*-driven transcript (Supplemental Figure 2). By 2.5 min, therefore, the gene has gone through several rounds of transcription. By 5 min, the amount of induction is near-maximal.

In our localization experiments, we detect GEV-GFP in the nucleus at 6--8 min following addition of β-estradiol to the media. If nuclear localization takes 6--8 min, how do we measure full-length transcripts at 2.5 min following β-estradiol to the medium? There are at least two potential explanations. First, the GEV-GFP fusion may have slightly slower kinetics of nuclear localization than GEV. Second, the kinetics of GEV-GFP reflects that of GEV without the fluorescent tag, but measuring localization is too insensitive to detect the first few GEV-GFP molecules that become localized to the nucleus and activate transcription.

Opportunities for dynamic studies of regulation
-----------------------------------------------

One of the most significant advantages of the system is the potential for following the consequences of the induction of a specific protein dynamically. This advantage is clearest in the case of a transcriptional regulator like Met4p, which we discuss further below. Not only can our understanding of the induction kinetics allow us to distinguish primary from secondary targets, but the cascade of consequences can be followed as time series that can shed light on the sequence of events under a variety of physiological conditions.

Through overexpression of *MET4,* we have shown that we can distinguish the kinetics of induction of the sulfur metabolic genes ([Figure 7](#F7){ref-type="fig"}). As we will present in a future study, the kinetics of target induction can depend strongly on the choice of nutrient limitation (i.e., phosphate vs. methionine limitation). ChIP-chip studies can show the presence or absence of transcription factor--DNA interactions. They fail, however, to capture the strength and kinetics of induction of a particular gene in response to a single factor, something that we are able to readily measure via GEV-mediated overexpression of particular transcription factors. Because of these advantages afforded by the GEV system, we are currently in the process of constructing a GEV-based, prototrophic collection of transcription factor overexpression strains.

On removing β-estradiol from the media, GEV-GFP begins to delocalize within minutes ([Figure 2B](#F2){ref-type="fig"}). How does delocalization occur so quickly? In the presence of β-estradiol, we can say that cytoplasmic GEV binds β-estradiol and enters the nucleus at the rate *k~in~*. Nucleus-localized GEV is either bound to or unbound from DNA. Unbound GEV diffuses throughout the nucleus and exits the nucleus at the rate *k~out~*. Because *k~in~* approaches 0 in the absence of β-estradiol, we can immediately measure unbound GEV leaving the nucleus the rate *k~out~*. The true rate of nuclear delocalization of GEV, however, includes the unbinding of GEV from DNA, which can be much slower.

Given that the nuclear half-life of GEV is ∼40 min and that protein half-lives can be many hours, removing β-estradiol from the media is not an effective way to quickly deplete the levels of a target protein. Similarly, methods that rely on blocking transcription upon addition of inducer to cells are not effective for rapidly depleting target proteins. These facts motivated us to drive the expression of TEV by GEV, which allows us to rapidly turn off target proteins containing an N-degron sequence. This sequence can readily be added to genes via homologous recombination. Therefore, we now have a method for rapidly shutting off the levels of single genes expressed from their native promoters. Upon β-estradiol addition and subsequent depletion of the target gene by TEV, we can study the cell\'s transient physiological response (such as the transcriptional profile) to losing both essential and nonessential genes. Importantly, these types of studies could help us to rigorously define the transcriptional regulatory network of essential genes in *S. cerevisiae.*

Opportunities for enhancement of the system
-------------------------------------------

There are still a few dozen genes that are induced or repressed significantly when GEV is induced with β-estradiol. One way to improve the system will be to replace GEV\'s Gal4dbd with a DNA binding domain from either a non-yeast transcription factor (such as LexA) or from custom-designed zinc fingers that recognize DNA sequences not found in *S. cerevisiae.* Ideally, we can choose a DNA binding domain with high target DNA specificity and low enough affinity for binding DNA that the chimeric protein binds only to a single sequence of interest.

Another area for extension of the system is the adaptation of other nuclear receptors that work by the same mechanism as that of GEV, so that independent induction of two target genes can be accomplished. With two independent inducing systems one could also induce synthesis of a target protein by adding one inducer, and then destroy, at will, the protein by inducing the TEV protease with the other inducer.

Conclusion
==========

To conclude, we believe that the GEV and TEV induction and protein degradation systems will allow new kinds of regulatory control of cells in vivo. Mutant studies generally require growing a defective strain up to study; with GEV one can avoid this by making expression of the gene dependent on gratuitous induction with β-estradiol, as we showed in the case of *TPS2* ([Figure 5](#F5){ref-type="fig"}). This feature was put to use in studying the growth effects of *met4* deletions, as was the opportunity to study the effect of loss of Met4p dynamically using the TEV system described here ([@B17]). For accurate assessment of the roles of genes and proteins in networks, dynamic perturbation of steady states still seems the most attractive approach, which we imagine will be facilitated by the technology introduced here.

MATERIALS AND METHODS
=====================

Strains
-------

We constructed prototrophic *HAP1^+^* yeast strains that can be readily modified to either 1) induce expression of a single gene or 2) rapidly degrade a single target protein. These strains contain an integrated copy of GEV driven by an *ACT1* promoter and are *gal4Δ gal1Δ.*

For induction/overexpression studies, we constructed GEV-containing strains of either mating type: DBY12020 (MAT**a**) and DBY12021 (MATα). These strains can be transformed with a KanMX4-P*~GAL1~* linear fragment ([@B26]) in front of any non-essential gene to make that gene inducible by β-estradiol.

For protein degradation studies, we constructed DBY12132 and DBY12200, which contain both GEV and the TEV protease. In DBY12132 and DBY12200, P*~ACT1~*-GEV is at the *LEU2* or *CAN1* locus, respectively. By modifying a target gene in these strains to contain a degron sequence recognized by TEV at its N-terminus, a gene can be expressed under its native promoter and degraded in the presence of β-estradiol.

Details of the strain construction can be found in the Supplementary Information. Relevant primers are provided in Supplemental Table 2.

Media and growth conditions
---------------------------

For microscopy and flow cytometry experiments, cells were grown in low-fluorescence medium (LFM). LFM is chemostat minimal medium ([@B6]) lacking riboflavin and folic acid, and contains, in addition to glucose (20 g/l), 5 g/l (NH~4~)~2~SO~4,~ 1 g/l KH~2~PO~4,~ 0.5 g/l MgSO~4,~ 0.1 g/l NaCl, 0.1 g/l Ca~2~Cl, 0.5 mg/l H~3~BO~4~, 0.04 mg/l CuSO~4,~ 0.1 mg/l KI, 0.2 mg/l FeCl~3~, 0.4 mg/l MnSO~4~, 0.2 mg/l Na~2~MoO~4~, 0.4 mg/l ZnSO~4~, 2 μg/l biotin, 0.4 mg/l calcium pantothenate, 2 mg/l inositol, 0.4 mg/l niacin, 0.2 mg/l *para*-aminobenzoic acid, 0.4 mg/l pyridoxine HCl, and 0.4 mg/l thiamine.

For induction experiments, yeast were cultured in 500 ml chemostats (Sixfors, Infors AG, Bottmingen, Switzerland) under phosphate limitation (20 mg/l potassium phosphate) and pulsed with 1 μM β-estradiol (Tocris Biosciences, Ellisville, MO) diluted from a 2.5 mM stock in ethanol. For the *MET4* induction experiment, phosphate-limited medium was supplemented with 200 mg/l methionine. Culture volume was maintained at 300 ml. Approximately 18 h of batch phase growth before pump turn-on was initiated from a 1:60 dilution of cells grown overnight in the same medium. Cultures were grown at 30°C, stirred at 400 rpm, and aerated at ∼6 l/min with filtered humidified air.

For all other experiments, cells were grown on rich medium (YPD; 2% peptone, 1% yeast extract, 2% glucose).

Microscopy
----------

For GEV localization studies, fluorescence was measured with an epifluorescence Nikon Eclipse-TI inverted microscope using a Nikon 40×/0.95 NA DIC Plan Apo objective. The microscope is equipped with a PerfectFocus system (Nikon) for maintaining the correct focal plane, a Clara CCD Camera (Andor DR328G; South Windsor, CT) for recording fluorescence emission, and a TI-S-ER motorized stage with encoders to ensure near-perfect return to marked stage positions (Nikon MEC56100). GEV-GFP emission was visualized at 525 nm (50-nm bandwidth) upon excitation at 470 nm (40-nm bandwidth; Chroma 49002_Nikon ETGFP filter cube). HTB2-mCherry emission was visualized at 620 nm (60-nm bandwidth) upon excitation at 545 nm (30-nm bandwidth; Chroma 96364_Nikon ET-DSRed filter cube). Image acquisition was automatically controlled using NIS Elements software (Nikon Instruments, Melville, NY).

For FISH, images were acquired with an Olympus IX81 inverted fluorescence microscope as described in [@B38].

GEV-GFP localization experiment
-------------------------------

Cultures of DBY11415 were grown in LFM overnight to saturation. Overnight cultures were diluted 1:50 in fresh LFM to a Klett of ∼10 (Klett-Summerson Colorimeter). The Klett was monitored, and at Klett 40 cells were loaded into 96-well glass-bottom optical plates for microscopy (Nunc 265300; Thermo Fisher Scientific, Rochester, NY). Each well in the 96-well plate was incubated with 30 μl of concanavalin A solution (2 mg/ml concanavalin A \[MP Biomedicals 150710\] dissolved in 5 mM MnCl~2~ 5 mM CaCl~2~, pH 6.5) to fix cells to the bottom of the plate. After a 5 min incubation, excess concanavalin A was aspirated off, and 4 μl of cell culture + 91 μl of fresh LFM + 1 μl of 100% ethanol were added to each well. Cells were allowed to settle to the bottom of each well while stage positions were marked on the microscope using ambient room light.

Cells were imaged immediately before and immediately after addition of 4 μl of β-estradiol to each well. Each experiment was done in triplicate, and two images were taken per well of the 96-well plate, resulting in six image frames per concentration of β-estradiol. Images were acquired every 170 s during induction of GEV-GFP localization.

GEV-GFP washout experiment
--------------------------

DBY11415 cells were maintained in a flow cell (Bioptechs FCS2; Butler, PA) during microscopy. Cells were adhered to the bottom of a 40-mm round coverslip by first incubating the coverslip with concanavalin A, and then the coverslip was assembled into the FCS2 chamber. Cells were maintained at room temperature during the course of the experiment (25°C). The Klett of the culture was 110 when cells were loaded into the flow cell. Two peristaltic pumps (Instech P720; Plymouth Meeting, PA) were alternately used to perfuse medium to cells during microscopy. One pump perfused LFM, and the other perfused LFM with 1 μM β-estradiol. The pump flow rates were automatically controlled by computer (Bioptechs Perfusion Controller), and by switching between pumps we were able to exchange media within the cell chamber in ∼2 min. GEV nuclear localization was first induced with LFM + 1 μM β-estradiol for 50 min. The pump flow rates were then switched, and images were acquired every 300 s to monitor delocalization of GEV-GFP. Conditions for imaging GFP and mCherry were identical to the induction experiment except that a 1.5X optovar was inserted into the optical path to magnify images from 40X to 60X.

GEV-GFP image processing
------------------------

Image processing was performed by preprocessing the images in ImageJ and then using a custom-written Matlab script to extract the intensities in the nuclei relative to the cytoplasm. Code is available upon request. Briefly, the image processing was done as follows: Fluorescence images were background subtracted using the rolling ball background subtraction command in ImageJ using a ball radius of 50 pixels. The method has been previously described ([@B39]). Images were examined by eye in ImageJ, and out-of-focus images were removed before further analysis.

These preprocessed images were then analyzed using a custom-written Matlab script. In brief, the code first identifies cells using various thresholding commands on the GFP images to create a "mask" of the image (an image in which pixels inside of cells are identified as 1 and pixels outside of cells are identified as 0). The user is then given an opportunity to correct any errors in this mask by hand. The code then uses similar thresholding commands on the mCherry image to identify cell nuclei and create a mask for the nuclei. Using these two masks the script then extracts intensity information from the GFP image for each cell identified in the cell mask, using the nucleus mask to differentiate between the cytoplasm and the nucleus. A particle-tracking routine (track.m from <http://physics.georgetown.edu/matlab/index.html>) is then used to align values for cells and nuclei between images taken at different time points. Finally, the various parameters are exported as cell-by-time matrices in which each row represents a single cell identified throughout the time course. The Localization Score in all figures is determined for each cell by first averaging the top 5% of pixel intensities and then subtracting from this number the average pixel intensity over the entire cell ([@B7]).

FISH
----

FISH probe design and experiments were performed as described by [@B38]). DBY12040 was grown to early-log phase and pulsed with 1 μM β-estradiol. Cells were fixed before β-estradiol addition to the culture, and at 2 and 8 min ([Figure 3B](#F3){ref-type="fig"}) following β-estradiol addition. The Cy3-labeled DNA probes used for FISH are listed in Supplemental Table 3.

Flow cytometry
--------------

Cell fluorescence was measured with a BD LSRII Multi-Laser Analyzer with HTS (BD Biosciences, Sparks, MD). High fluorescence in single cells was determined from the distribution of fluorescent intensities in cells lacking GFP (the distribution was determined from the fluorescence values of 100,000 cells). The cutoff for high fluorescence was set at the top 0.2% of the distribution (GFP signal = 190 au).

Growth curves
-------------

Cells and media (100 μl) were grown on flat-bottom, 96-well plates (Costar 3631). A~600~ was measured every 15 min in a Synergy HT (Bio Tek, Winooski, VT) microplate reader. Cells were grown at 30°C with medium shaking. Growth rates were computed with spline-fits using the *grofit* R package ([@B23]).

Microarrays and functional annotation
-------------------------------------

RNA from cells was extracted, labeled, and hybridized to Agilent (Santa Clara, CA) expression microarrays as described by Brauer *et al.* ([@B6]) with slight modifications. Briefly, RNA was extracted from frozen cells with a standard acid--phenol method and then cleaned with RNeasy (Qiagen, Valencia, CA). Cleaned mRNA was then converted to cDNA and subsequently converted to labeled cRNA with the Agilent Quick-Amp Labeling Kit (Part No. 5190-0424). Hybridization to 8 x 15k Agilent microarrays (Agilent, Santa Clara, CA) was performed for 17 h at 65°C while rotating on a rotisserie at 20 rpm. Microarrays were washed and then scanned with Agilent Feature Extractor Software version 9.5. Flagged features marked as unreliable were marked N/A. Raw green- and red-channel intensities were floored to a value of 350 (i.e., intensities \< 350 were set equal to 350). If the numerator (red-channel, sample RNA) for a given measurement was floored, the denominator (green-channel, reference RNA) for that measurement was set to the average green channel intensity for that gene. The purpose of this smoothing process is to make genes with negligible red-channel signal intensity less sensitive to small fluctuations in the reference intensity. After flooring of the data, the log2 ratios were computed.

For time series experiments, 5 ml of cells was taken per culture per time point. Reference RNA was taken from DBY12001 grown in a phosphate-limited chemostat at a dilution rate of 0.18h^−1^. Enrichment for Gene Ontology (GO) terms was determined using the Generic Gene Ontology Term Finder ([@B5]).

Construction of the degron system
---------------------------------

The degron system consists of two parts, each of which ends up inserted into the chromosome. One of these is the protease cassette, consisting of the *GAL1* promoter, a modified TEV protease-coding region, the spliceosome subunit p14 peptide, a *CYC1* terminator, and a selectable (hygromycin) marker, all integrated to replace the genomic *GAL1* coding sequence. The details of this construction are described in the Supplemental Material. The second part is a simple way to insert the degron/marker cassette at any promoter of interest. To this end, we constructed a generic template for PCR (plasmid pRB3326) that enables the placement of our modified degron/marker cassette at the initiator methionine codon of any open reading frame (details are also found in the Supplemental Material).

Modification of target genes to make them TEV-sensitive
-------------------------------------------------------

Because native proteins are not sensitive to the TEV protease, a generic system was adapted from [@B42] to make the required modifications of any gene routine. The overall idea is to generate a native-promoter driven, degron-modified gene. A particular new feature of our method is the inclusion of a removable (CRE-LOX) segment that results in loss of the selectable marker. The details of this construction, and its application to the specific cases of *MET4* and *MET31,* are given in the Supplemental Material.

Construction of *can1Δ*::P~ACT1~-GEV strains
--------------------------------------------

The *P~ACT1~*-GEV construct was amplified from the pAGL plasmid ([@B43]) using oligonucleotides containing 56-59 bases of sequence identity to the flanking region of the *CAN1* gene (ACT1-GEV_to_CAN1 FOR and ACT1-GEV_to_CAN1 REV). This PCR product was then transformed into either MAT**a** or MATα wild-type prototrophic yeast cells by using a standard protocol selecting for canavanine resistance.

Western blots
-------------

Total protein was extracted from ∼10 ml aliquots of cultures at ∼2 × 10^7^ cells/ml by using the YPX extraction kit (Protein Discovery, Knoxville, TN) with the addition of protease inhibitors (Roche tablets, cat\#11836170001; Basel, Switzerland). Proteins were separated using Invitrogen NuPage precast 10% Bis-Tris gels and transferred to Invitrolon polyvinylidene fluoride (Invitrogen cat\# LC2005; Carlsbad, CA) according to the manufacturer\'s protocols. Primary antibody for the 13-Myc epitope was mouse anti--human c-Myc from BD PharMingen (cat\# 51-1485GR; San Diego, CA). Secondary antibody was goat anti--mouse-horseradish peroxidase (HRP; cat\# 115-035-003) from Jackson ImmunoResearch (West Grove, PA). Primary antibody dilution was typically 1:1000, and secondary antibodies were used at a 1:10,000 dilution. Immunoreactive peptides were detected by incubation with ECL^+^ detection reagent (Amersham/GE RPN2132; Little Chalfont, UK) and imaging on HyBlot CL autoradiography film (Denville Scientific, Metuchen, NJ). As a loading control, we probed blots with mouse monoclonal anti--β-actin antibody (cat\# ab8224; Abcam, Cambridge, MA). Secondary antibody was as above, goat anti--mouse-HRP. Protein levels were quantified with the "Gel Analysis" feature in ImageJ and normalized to the t = 0 levels in each time course.

Supplementary Material
======================
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:   fluorescence in situ hybridization
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:   Gal4p DNA binding domain

GEV
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:   isopropyl β-[d]{.smallcaps}-1 thiogalactopyranoside
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:   low-fluorescence medium
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:   TEV cleavable peptide
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:   reverse tetracycline transactivator
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